Brandywine Managers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,627
Closed -$253K 41
2022
Q2
$253K Hold
7,627
0.62% 35
2022
Q1
$550K Hold
7,627
0.95% 31
2021
Q4
$700K Hold
7,627
0.79% 28
2021
Q3
$967K Hold
7,627
1.01% 22
2021
Q2
$1.27M Buy
7,627
+327
+4% +$53K 1.45% 15
2021
Q1
$1.33M Hold
7,300
1.76% 10
2020
Q4
$1.46M Hold
7,300
2.01% 9
2020
Q3
$1.6M Hold
7,300
3.04% 6
2020
Q2
$1.39M Hold
7,300
5.72% 4
2020
Q1
$1.13M Sell
7,300
-300
-4% -$34.9K 0.4% 3
2019
Q4
$636K Hold
7,600
0.19% 21
2019
Q3
$515K Hold
7,600
0.17% 20
2019
Q2
$505K Hold
7,600
0.19% 28
2019
Q1
$423K Sell
7,600
-200
-3% -$12.2K 0.17% 30
2018
Q4
$387K Buy
7,800
+1,300
+20% +$79.5K 0.18% 22
2018
Q3
$561K Hold
6,500
0.24% 21
2018
Q2
$377K Sell
6,500
-300
-4% -$14.7K 0.15% 24
2018
Q1
$274K Hold
6,800
0.15% 26
2017
Q4
$237K Buy
6,800
+200
+3% +$6.64K 0.07% 24
2017
Q3
$219K Buy
+6,600
New +$216K 0.06% 27

Other funds holding TDOC

Brandywine Managers's TDOC Position: Q3 2022 in Review

Brandywine Managers sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 7,627 shares — an estimated $253K sold.

Brandywine Managers first reported a position in TDOC in Q3 2017 and held it in 20 quarters. The position peaked at $1.6M in Q3 2020. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Brandywine Managers reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Brandywine Managers sold 7,627 Teladoc Health shares in Q3 2022, an estimated $253K.
  • Brandywine Managers first reported a position in Teladoc Health in Q3 2017 and held it in 20 quarters.
  • Brandywine Managers's Teladoc Health position peaked at $1.6M in Q3 2020.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Brandywine Managers's 13F filing for Q3 2022, filed 14 Nov 2022.